203 related articles for article (PubMed ID: 27377463)
1. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.
Chuang LS; Villaverde N; Hui KY; Mortha A; Rahman A; Levine AP; Haritunians T; Evelyn Ng SM; Zhang W; Hsu NY; Facey JA; Luong T; Fernandez-Hernandez H; Li D; Rivas M; Schiff ER; Gusev A; Schumm LP; Bowen BM; Sharma Y; Ning K; Remark R; Gnjatic S; Legnani P; George J; Sands BE; Stempak JM; Datta LW; Lipka S; Katz S; Cheifetz AS; Barzilai N; Pontikos N; Abraham C; Dubinsky MJ; Targan S; Taylor K; Rotter JI; Scherl EJ; Desnick RJ; Abreu MT; Zhao H; Atzmon G; Pe'er I; Kugathasan S; Hakonarson H; McCauley JL; Lencz T; Darvasi A; Plagnol V; Silverberg MS; Muise AM; Brant SR; Daly MJ; Segal AW; Duerr RH; Merad M; McGovern DP; Peter I; Cho JH
Gastroenterology; 2016 Oct; 151(4):710-723.e2. PubMed ID: 27377463
[TBL] [Abstract][Full Text] [Related]
2. Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families.
Levine AP; Pontikos N; Schiff ER; Jostins L; Speed D; ; Lovat LB; Barrett JC; Grasberger H; Plagnol V; Segal AW
Gastroenterology; 2016 Oct; 151(4):698-709. PubMed ID: 27373512
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease.
Denson LA; Jurickova I; Karns R; Shaw KA; Cutler DJ; Okou D; Valencia CA; Dodd A; Mondal K; Aronow BJ; Haberman Y; Linn A; Price A; Bezold R; Lake K; Jackson K; Walters TD; Griffiths A; Baldassano RN; Noe JD; Hyams JS; Crandall WV; Kirschner BS; Heyman MB; Snapper S; Guthery SL; Dubinsky MC; Leleiko NS; Otley AR; Xavier RJ; Stevens C; Daly MJ; Zwick ME; Kugathasan S
Inflamm Bowel Dis; 2019 Feb; 25(3):547-560. PubMed ID: 30124884
[TBL] [Abstract][Full Text] [Related]
4. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
[TBL] [Abstract][Full Text] [Related]
5. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients.
Fidder HH; Olschwang S; Avidan B; Zouali H; Lang A; Bardan E; Picard O; Bar-Meir S; Colombel JF; Chowers Y
Am J Med Genet A; 2003 Sep; 121A(3):240-4. PubMed ID: 12923865
[TBL] [Abstract][Full Text] [Related]
6. Intracerebral GM-CSF contributes to transendothelial monocyte migration in APP/PS1 Alzheimer's disease mice.
Shang S; Yang YM; Zhang H; Tian L; Jiang JS; Dong YB; Zhang K; Li B; Zhao WD; Fang WG; Chen YH
J Cereb Blood Flow Metab; 2016 Nov; 36(11):1978-1991. PubMed ID: 27444968
[TBL] [Abstract][Full Text] [Related]
7. Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.
Jurickova I; Collins MH; Chalk C; Seese A; Bezold R; Lake K; von Allmen D; Frischer JS; Falcone RA; Trapnell BC; Denson LA
Clin Exp Immunol; 2013 Jun; 172(3):455-65. PubMed ID: 23600834
[TBL] [Abstract][Full Text] [Related]
8. The Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity.
Croxford AL; Lanzinger M; Hartmann FJ; Schreiner B; Mair F; Pelczar P; Clausen BE; Jung S; Greter M; Becher B
Immunity; 2015 Sep; 43(3):502-14. PubMed ID: 26341401
[TBL] [Abstract][Full Text] [Related]
9. Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease.
Goldstein JI; Kominsky DJ; Jacobson N; Bowers B; Regalia K; Austin GL; Yousefi M; Falta MT; Fontenot AP; Gerich ME; Golden-Mason L; Colgan SP
Gastroenterology; 2011 Jul; 141(1):208-16. PubMed ID: 21557945
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease.
Han X; Uchida K; Jurickova I; Koch D; Willson T; Samson C; Bonkowski E; Trauernicht A; Kim MO; Tomer G; Dubinsky M; Plevy S; Kugathsan S; Trapnell BC; Denson LA
Gastroenterology; 2009 Apr; 136(4):1261-71, e1-3. PubMed ID: 19230854
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Mortha A; Remark R; Del Valle DM; Chuang LS; Chai Z; Alves I; Azevedo C; Gaifem J; Martin J; Petralia F; Tuballes K; Barcessat V; Tai SL; Huang HH; Laface I; Jerez YA; Boschetti G; Villaverde N; Wang MD; Korie UM; Murray J; Choung RS; Sato T; Laird RM; Plevy S; Rahman A; Torres J; Porter C; Riddle MS; Kenigsberg E; Pinho SS; Cho JH; Merad M; Colombel JF; Gnjatic S
Gastroenterology; 2022 Sep; 163(3):659-670. PubMed ID: 35623454
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.
Däbritz J
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G455-65. PubMed ID: 24503766
[TBL] [Abstract][Full Text] [Related]
13. Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3.
Zhang W; Hui KY; Gusev A; Warner N; Ng SM; Ferguson J; Choi M; Burberry A; Abraham C; Mayer L; Desnick RJ; Cardinale CJ; Hakonarson H; Waterman M; Chowers Y; Karban A; Brant SR; Silverberg MS; Gregersen PK; Katz S; Lifton RP; Zhao H; Nuñez G; Pe'er I; Peter I; Cho JH
Genes Immun; 2013; 14(5):310-6. PubMed ID: 23615072
[TBL] [Abstract][Full Text] [Related]
14. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease.
Sanders TJ; McCarthy NE; Giles EM; Davidson KL; Haltalli ML; Hazell S; Lindsay JO; Stagg AJ
Gastroenterology; 2014 May; 146(5):1278-88.e1-2. PubMed ID: 24503130
[TBL] [Abstract][Full Text] [Related]
15. Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.
Zhou Z; Lin XY; Akolkar PN; Gulwani-Akolkar B; Levine J; Katz S; Silver J
Am J Gastroenterol; 2002 Dec; 97(12):3095-101. PubMed ID: 12492195
[TBL] [Abstract][Full Text] [Related]
16. Impaired granulocyte-macrophage colony-stimulating factor bioactivity accelerates surgical recurrence in ileal Crohn's disease.
Gathungu G; Zhang Y; Tian X; Bonkowski E; Rowehl L; Krumsiek J; Nix B; Chalk C; Trapnell B; Zhu W; Newberry R; Denson L; Li E
World J Gastroenterol; 2018 Feb; 24(5):623-630. PubMed ID: 29434451
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
[TBL] [Abstract][Full Text] [Related]
18. CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.
Javadi M; Richmond TD; Huang K; Barber DL
J Biol Chem; 2013 Jul; 288(27):19459-70. PubMed ID: 23696637
[TBL] [Abstract][Full Text] [Related]
19. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.
Bonen DK; Ogura Y; Nicolae DL; Inohara N; Saab L; Tanabe T; Chen FF; Foster SJ; Duerr RH; Brant SR; Cho JH; Nuñez G
Gastroenterology; 2003 Jan; 124(1):140-6. PubMed ID: 12512038
[TBL] [Abstract][Full Text] [Related]
20. CARD15 frameshift mutation in patients with CROHN disease is associated with immune dysregulation.
Halme L; Turunen U; Paavola-Sakki P; Heliö T; Lappalainen M; Färkkilä M; Kontula K; Repo H
Scand J Gastroenterol; 2004 Dec; 39(12):1243-9. PubMed ID: 15743002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
